a clinical-stage company, which engages in developing treatments for rare and specialty diseases with significant unmet needs.
Industry Biotechnology
A.I.dvisor tells us that TARA and VERA have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that TARA and VERA's prices will move in lockstep.
Ticker / NAME | Correlation To TARA | 1D Price Change % | ||
---|---|---|---|---|
TARA | 100% | -4.00% | ||
VERA - TARA | 31% Poorly correlated | +1.43% | ||
PSTX - TARA | 30% Poorly correlated | N/A | ||
ATYR - TARA | 30% Poorly correlated | -4.81% | ||
CDXS - TARA | 28% Poorly correlated | -1.38% | ||
PRME - TARA | 28% Poorly correlated | -9.81% | ||
More |